Picture of Biovaxys Technology logo

BIOV Biovaxys Technology Income Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual income statement for Biovaxys Technology, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.

2018
October 31st
R2019
October 31st
2020
October 31st
2021
October 31st
Period Length:12 M12 M12 M12 M
Source:ARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
Total Revenue0000
Selling / General / Administrative Expenses
Research And Development
Total Operating Expenses0.1610.2171.16.44
Operating Profit-0.161-0.217-1.1-6.44
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-0.161-0.217-1.1-6.46
Net Income After Taxes-0.161-0.217-1.1-6.46
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-0.161-0.23-1.17-6.46
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-0.161-0.23-1.17-6.46
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.008-0.01-0.039-0.078
Dividends per Share

Or unlock with your email

Or unlock with your email